Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 38,318 | 36,017 | 28,990 | 31,428 | 28,682 |
| Operating Income | -38,318 | -36,017 | -28,990 | -31,428 | -28,682 |
| Other Income | 3,752 | 4,054 | 3,979 | 3,098 | 3,204 |
| Pre-tax Income | -34,566 | -31,963 | -25,011 | -28,330 | -25,478 |
| Net Income Continuous | -34,566 | -31,963 | -25,011 | -28,330 | -25,478 |
| Net Income | $-34,566 | $-31,963 | $-25,011 | $-28,330 | $-25,478 |
| EPS Basic Total Ops | -0.49 | -0.45 | -0.37 | -0.49 | -0.44 |
| EPS Basic Continuous Ops | -0.49 | -0.45 | -0.37 | -0.48 | -0.44 |
| EPS Diluted Total Ops | -0.49 | -0.45 | -0.37 | -0.49 | -0.44 |
| EPS Diluted Continuous Ops | -0.49 | -0.45 | -0.37 | -0.48 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.45 | -0.37 | N/A | N/A |
| EBITDA(a) | $-39,994 | $-38,041 | $-30,956 | $-33,288 | $-30,347 |